RVT-1502: Clinical Trials

3 trials of RVT-1502, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow RVT-1502: new trials by email Literature Review of RVT-1502 trials Research Report on RVT-1502

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation
LGD-6972 Solution, LGD-6972 Capsules - Type 2 Diabetes Mellitus (T2DM)
Phase 1CompletedLigand Pharmaceuticals122016-02-012016-05-18
Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus
LGD-6972, Placebo (Captisol ®) - Type 2 Diabetes Mellitus
Phase 1CompletedLigand Pharmaceuticals482014-10-012015-06-11
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus
LGD-6972, Placebo (Captisol®) - Type 2 Diabetes Mellitus
Phase 1CompletedLigand Pharmaceuticals562013-11-012014-09-25

Conditions studied

Diabetes Mellitus, Type 2 (3)

Sponsors

Ligand Pharmaceuticals (3)

Countries

United States (3)

Top investigators

Douglas K Logan, M.D. (1)  ·  Keith Marschke, Ph.D. (1)  ·  Lukasz Biernat, M.D. (1)